The Δ serum HER2 level was positively associated with tumor burden, as measured synchronously by computed tomography (CT) and blood sampling for serum HER2 examination (Figure 5C, correlation coefficient = 0.522, p = 0.006). The gene discussed is ERBB2; the disease is neoplasm.